Metformin therapy and assessment for vitamin B 12 deficiency: is it necessary?
Practical Diabetes · 2011
DOI: 10.1002/pdi.1619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Diabetes, 2011. Verfasst von SA Qureshi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Metformin therapy in type 2 diabetes mellitus (T2DM) has been recognised as a cause of vitamin B 12 deficiency for at least 40 years, but routine measurement is not currently advocated in clinical guidelines. Assessment might be of particular relevance in T2DM complicated by peripheral neuropathy. This service review examined whether serum vitamin B 12 levels were measured in patients with high dose (>2g/day) and long‐term (four years) metformin treatment, in particular among those with peripheral neuropathy. We also evaluated the effectiveness of vitamin B 12 replacement when levels were low. Of 283 patients on high dose metformin for more than four years only, 70 (25%) had vitamin B 12 levels checked. All of these 70 cases had peripheral neuropathy. Vitamin B 12 deficiency (
Zitieren
APA
Qureshi, S., Ainsworth, A., & Winocour, P. (2011). Metformin therapy and assessment for vitamin B 12 deficiency: is it necessary?. Practical Diabetes. https://doi.org/10.1002/pdi.1619
Vancouver
Qureshi S, Ainsworth A, Winocour P. Metformin therapy and assessment for vitamin B 12 deficiency: is it necessary?. Practical Diabetes. 2011. doi:10.1002/pdi.1619
BibTeX
@article{Qureshi2011,
author = {Qureshi, SA and Ainsworth, A and Winocour, PH},
title = {Metformin therapy and assessment for vitamin B 12 deficiency: is it necessary?},
journal = {Practical Diabetes},
year = {2011},
doi = {10.1002/pdi.1619}
}
EUVIMED